Fortrea increases patient access capabilities and cold chain expertise

Published: 21-Feb-2024

Fortrea’s non-commercial specialty pharmacy expansion delivers flexible, scalable solutions to customers and medications direct to patients

Fortress, a global contract research organisation (CRO), today announced the opening of its expanded non-commercial specialty pharmacy.

FortreaRx, located in Lake Mary, Florida, offers advanced patient access solutions across the US, including ambient and cold-chain distribution capabilities and expertise. 

Licensed in all 50 states and US territories, FortreaRx delivers flexible, scalable solutions that meet the specific needs of its customers while providing medications to patients who may otherwise not have access to them. 

Non-commercial specialty pharmacies, provide solutions on behalf of their pharmaceutical manufacturer customers, and are uniquely positioned to serve as a bridge between pharmaceutical manufacturers and patients who meet the manufacturer requirements for prescription assistance.

Since FortreaRx’s inception in late 2008, Fortrea has pioneered non-commercial specialty pharmacy services, focusing exclusively on the distribution of free-goods products as an integrated component of pharmaceutical manufacturer-sponsored patient assistance programmes (PAP). 

They are designed to expand access to therapy for qualified patients with no health insurance, or those who are underinsured. 

The FortreaRx 40,000sqft facility doubles its operational space and bolsters its capabilities, delivering:

  • 1,800 sqft of ambient storage
  • 6,000+ sqft of cold chain storage with more than 85% of prescriptions filled by FortreaRx requiring this unique handling
  • Greater processing and fulfillment space for up to 18000 prescriptions daily
  • Enhanced shipping solutions with options for overnight, expedited and 2-day deliveries

"Fortrea’s patient service offerings, combined with the expanded capabilities of FortreaRx, deliver an end-to-end approach, from early clinical stages to post-market delivery. This ensures a comprehensive and personalised experience for patients," said Bill Nolan, Vice President and global head of Patient Access at Fortrea. 

You may also like